Milestone Scientific Inc. (MLSS) stock
MLSSNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3018% below fair value
$0.28−0.02 (-5.78%)
Close on Nov 17, 2026Market cap $24.58MP/E –Yield –
Milestone Scientific operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Milestone Scientific's operating cash flow for the twelve months ending Jun 30, 2026 was -$642.64K. For fiscal 2025 it was -$2.92M. The highest annual figure on record is $1.26M in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.92M | – |
| FY2024 | Dec 31, 2024 | -$2.92M | – |
| FY2023 | Dec 31, 2023 | -$5.33M | – |
| FY2022 | Dec 31, 2022 | -$6.03M | – |
| FY2021 | Dec 31, 2021 | -$4.03M | – |
| FY2020 | Dec 31, 2020 | -$6.98M | – |
| FY2019 | Dec 31, 2019 | -$1.78M | – |
| FY2018 | Dec 31, 2018 | -$1.63M | – |
| FY2017 | Dec 31, 2017 | -$1.23M | – |
| FY2016 | Dec 31, 2016 | -$5.40M | – |
| FY2015 | Dec 31, 2015 | -$2.95M | -881.6% |
| FY2014 | Dec 31, 2014 | $376.94K | -70.1% |
| FY2013 | Dec 31, 2013 | $1.26M | – |
| FY2012 | Dec 31, 2012 | -$49.72K | – |
| FY2011 | Dec 31, 2011 | -$570.73K | – |
| FY2010 | Dec 31, 2010 | -$293.78K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$585.13K | – |
| Q1 FY2026 | Mar 31, 2026 | $86.84K | – |
| Q4 FY2025 | Dec 31, 2025 | -$226.13K | – |
| Q3 FY2025 | Sep 30, 2025 | $81.78K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.76M | -325.1% |
| Q1 FY2025 | Mar 31, 2025 | -$1.01M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.51M | – |
| Q3 FY2024 | Sep 30, 2024 | -$973.91K | – |
| Q2 FY2024 | Jun 30, 2024 | $783.66K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.22M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.25M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.05M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.02M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.00M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.09M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.14M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.29M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.51M | – |
| Q4 FY2021 | Dec 31, 2021 | -$404.64K | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.56M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.10M | – |
| Q1 FY2021 | Mar 31, 2021 | -$967.81K | – |
| Q4 FY2020 | Dec 31, 2020 | -$638.77K | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.23M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.14M | – |
| Q1 FY2020 | Mar 31, 2020 | -$972.08K | – |
| Q4 FY2019 | Dec 31, 2019 | -$503.60K | -252.8% |
| Q3 FY2019 | Sep 30, 2019 | -$653.41K | – |
| Q2 FY2019 | Jun 30, 2019 | -$402.11K | – |
| Q1 FY2019 | Mar 31, 2019 | -$220.17K | – |
| Q4 FY2018 | Dec 31, 2018 | $329.50K | -0.4% |
| Q3 FY2018 | Sep 30, 2018 | -$440.83K | – |
| Q2 FY2018 | Jun 30, 2018 | -$975.42K | – |
| Q1 FY2018 | Mar 31, 2018 | -$541.35K | – |
| Q4 FY2017 | Dec 31, 2017 | $330.72K | – |
| Q3 FY2017 | Sep 30, 2017 | -$607.77K | – |
| Q2 FY2017 | Jun 30, 2017 | -$78.38K | – |
| Q1 FY2017 | Mar 31, 2017 | -$874.01K | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.28M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.10M | – |
See a number that looks wrong?